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atherogenic mechanisms, and the role of mediators they reduce intimal thickening in a mouse model of vascular release is not fully understood. In this issue of Carinjury [9, 10] . It has been demonstrated that mast cell diovascular Research, Huang et al. [1] provide evidence degranulation can induce apoptosis of rat cardiomyocytes that mast cells can contribute to stress related cardiac and stimulate proliferation of non-myocardial cells, a disease. They showed that mast cells become activated in situation that would lead to the progression of myocardial response to acute restraint stress in mice. This effect was fibrosis and a loss in contractile function [11] . This effect enhanced in ApoE knock-out mice. These mice were seen was attributable to the protease action of rat mast cell to have higher levels of histamine and a greater number of chymase. In a study examining coronary arteries obtained mast cells, compared to wild type. The findings provide from patients at autopsy, a 5-10-fold increase in mast cell important evidence that acute coronary syndromes can be numbers in cap, core and shoulder regions of atherosmediated by neuroinflammatory reactions.
clerotic lesions were observed. In the shoulder region, 85% Mast cells are found within every major organ of the of the mast cells were activated [12] . Chymase and body. Within the heart they can be localised to the tryptase released by mast cells may destabilise atheromatus interstitial space between myocytes, generally in regions plaques due to their action on the extracellular matrix. associated with the coronary arteries [2] . Mast cells are Both chymase and tryptase can directly activate matrix also found within media and adventitia of the coronary metalloproteinases (MMPs), cleave and activate procolvessels, with the majority residing in adventitia [3] . Mast lagenase, or stimulate the release of TNF-a which in turn cell numbers have been shown to increase during heart activate macrophages to secrete MMPs [7, 13, 14] . failure, with great numbers found in patients with
The contents of mast cells may have an important role to idopathic and ischaemic cardiomyopathy [4] . Greater play in coronary artery vasoconstriction associated with numbers of mast cells are also associated with the shoulder acute coronary syndromes. Intra-coronary injections of region of atherosclerotic plaques [5] . Those coronary histamine have been shown to induce vasoconstriction of vessels that are associated with myocardial infarction have atherosclerotic segments of the artery, but not in nonbeen shown to increase their numbers of degranulated mast diseased regions [15, 16] . Indeed, histamine has been cells within the adventitia of regions associated with shown to act as a 'double agent' in human arteries, plaque rupture. Within atherosclerotic lesions mast cells producing both relaxation and contraction [17] . The senare associated with activated complement, T-lymphocytes sitivity of atherosclerotic regions of the vessel wall is most and macrophages [6, 7] . Mast cells release a repertoire of likely due to either endothelial dysfunction at these sites, atherogenic mediators including proteases, chemokines, and / or up-regulation of histaminergic receptors in spastic areas of diseased coronary arteries. Other vasoactive agents released by mast cells, namely prostaglandin D and 2 leukotriene C will also contribute to the contractile effects constricts human arteries and veins [18] . Its contractile very early stages of the disease, angiotensin, via stimulaeffect in the coronary circulation is only observed in tion of adhesion molecules, can aid in the recruitment of atherosclerotic coronary [19] . monocytes / macrophages into the vessel wall [28] . AnMast cells participate in the early events of the atherosgiotensin may assist in the development of these cells into clerotic process. Increased numbers of mast cells have foam cells by enhancing oxidant stress by activation of been identified in fatty streaks, indicating their in-NADP/ NADPH oxidase, which leads to oxidation of LDL volvement in foam cell formation [20] . Mast cell activation [29] . Increases in oxidant stress will also down-regulate stimulates the transport of LDLs across the endothelium the protective effects of endothelium-derived nitric oxide. and into extravascular areas [21] . Heparin proteoglycans Superimposed on these mechanisms are the direct effects released from mast cell granules bind LDLs and are then of angiotensin II on the vascular smooth muscle cells. Its phagocytosed by macrophages [22] . Mast cell granules can mitogenic action, together with stimulation of messengers also partially degrade apolipoprotein B, leading to fusion such as transforming growth factor-b and plasminogen of LDL particles and uptake by macrophages [20] . Indeed, activator inhibitor-1 mediate the remodelling of the vessel it has been shown that mast cell stabilising agents have the wall seen in the latter stages of the disease [30-32]. ability to inhibit foam cell formation [22] .
Mast cells therefore have the capacity to release a wide Mast cells release a number of different proteases such range of mediators that can contribute to the onset and as cathepsin G, cardioxypeptidase, tryptase and chymase.
progression of atherosclerotic disease. Understanding the These enzymes can stimulate extra-cellular matrix degraevents that initiate their activation is key to comprehending dation and vascular remodelling but also have the capacity the mechanisms that allow mast cell degranulation to to generate angiotensin II. Chymase in particular is associprecipitate acute angina and myocardial infarction. The ated with cardiovascular disease due its ability to generate observation that acute stress can act as a trigger to their angiotensin II. In a similar fashion to chymotrypsin, activation provides an insight into how acute stress can chymases hydrolyse peptide bonds at the COOH-termini of precipitate acute coronary syndromes. Investigations into hydrophobic aromatic residues. The degree of selectivity the identification of the mediator(s) and the signalling over which amino acids are hydrolysed is a function of the mechanisms involved in the translation of stress into extended substrate binding site of the chymase molecule.
activation of mast cells are required. Additional studies are Thus, human chymase can form angiotensin II by cleavage warranted to elucidate how chronic stress may induce 8 9 of the bond between Phe -His of the precursor molecule, continued mast cell activation, and if such a mechanism is but it is unable to inactivate angiotensin II since it does not important in atherogenesis. Such studies will permit as-4 5
cleave the Tyr -Ile bond in angiotensin II. It is also sessment of the potential benefit of mast cell stabilising inactive against substance P, bradykinin, vasoactive intestiagents in the treatment of atherosclerosis. nal peptide, lutenizing hormone-releasing hormone, somatostatin and alpha-melanocyte-stimulating hormone [23] . Human chymase has been located in the mesenchym-R eferences al interstitial cells and endothelial cells within the heart [2] . Mast cells represent an important source of chymase with It has also been shown that interacting fibroblasts and mast 
